Relationship Between Tumor Gene Expression and Recurrence in Four Independent Studies of Patients With Stage II/III Colon Cancer Treated With Surgery Alone or Surgery Plus Adjuvant Fluorouracil Plus Leucovorin

Journal of Clinical Oncology - United States
doi 10.1200/jco.2010.28.9538
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine

Clinical Colorectal Cancer
OncologyGastroenterology
2017English

Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer

JAMA - Journal of the American Medical Association
Medicine
2012English

Serum Iron Levels as a New Biomarker in Chemotherapy With Leucovorin and Fluorouracil Plus Oxaliplatin or Leucovorin and Fluorouracil Plus Irinotecan, With or Without Molecularly-Targeted Drugs

Molecular and Clinical Oncology
Cancer ResearchOncology
2013English

Quality of Life in Metastatic Pancreatic Cancer Patients Receiving Liposomal Irinotecan Plus 5-Fluorouracil and Leucovorin

European Journal of Cancer
Cancer ResearchOncology
2019English

Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2013English

P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy

British Journal of Cancer
Cancer ResearchOncology
2019English

Comparative Analysis of the Efficacy and Safety of Chemotherapy With Oxaliplatin Plus Fluorouracil/Leucovorin Between Elderly Patients Over 65 Years and Younger Patients With Advanced Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2012English

2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy

Scripta Scientifica Medica
2015English

Phase II Study of Gefitinib, Fluorouracil, Leucovorin, and Oxaliplatin Therapy in Previously Treated Patients With Metastatic Colorectal Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy